C. Aylesworth

发表

A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors.

A. Tolcher, G. Weiss, D. V. Von Hoff, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

CT- and computer-based features of small hamartomas.

Ali O. Farooqi, A. Reeves, C. Henschke, 2011, Clinical imaging.

Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel.

M. Hidalgo, G. Weiss, C. Britten, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New or enlarging hiatal hernias after thoracic surgery for early lung cancer

J. Austin, E. Scalzetti, K. Rosenzweig, 2022, JTCVS open.

Acquired von willebrand's disease: A rare manifestation of postpartum thyroiditis

R. Smallridge, M. Rick, B. Alving, 1995, American journal of hematology.

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.

G. Weiss, D. V. Von Hoff, H. Burris, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies.

M. Hidalgo, D. V. Von Hoff, L. Smith, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia.

J. Byrd, W. Edenfield, N. Dawson, 1996, Leukemia & lymphoma.

A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignancies.

D. V. Von Hoff, T. Petit, P. Ravdin, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Diagnosis of heparin-induced thrombocytopenia in the vascular surgery patient.

M. R. Jackson, B. Alving, C. Aylesworth, 1997, Surgery.

Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.

M. Hidalgo, A. Tolcher, G. Weiss, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Docetaxel in combination with fluorouracil: study design and preliminary results.

D. V. Von Hoff, P. Ravdin, H. Burris, 1997, Oncology.

Effect of experimental cardiopulmonary bypass on systemic and transcardiac thromboxane B2 levels.

M. Buckley, W. Watkins, M. Peterson, 1986, The Journal of thoracic and cardiovascular surgery.

A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumors.

S. Davidson, M. Carducci, R. Donehower, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Survival with Parenchymal and Pleural Invasion of Non–Small Cell Lung Cancers Less than 30 mm

J. Austin, E. Scalzetti, A. Reeves, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.

E K Rowinsky, D. V. Von Hoff, E. Rowinsky, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Maintaining iron balance in women blood donors of childbearing age: summary of a workshop

G. Brittenham, V. Gordeuk, J. Kushner, 2002, Transfusion.

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies.

D. V. Von Hoff, S. Baker, M. Villalona-Calero, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumors.

S. Davidson, M. Carducci, R. Donehower, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.